600 patients66,869 observations120 daysLIVE

Patient P-01600

Synthetic patientNBL-101 · Day 116 · 35–44 · F · baseline S06Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
54%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S06
  2. Day 81 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 CR-01 recommendedClinician Review CR-01
  4. Day 83 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 81.

Primary contributors, last 14 days
  • GI instability-10
  • Inflammatory activity-7
  • Nutritional resilience+6
  • Treatment adherence-6

What helped?

  • Clinician Review CR-01Day 82
    Declined by patient
LIFE OS recommendation
GI Support Protocol GI-04
54%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
49.6/100
improving · -2.4 vs previous 14 d
Toxicity
Blood
57.5/100
worsening · +8.1 vs previous 14 d
Sleep quality
Wearable
14.1/100
improving · +2.0 vs previous 14 d
Energy level
Daily log
3.3/10
worsening · -0.1 vs previous 14 d
Stress level
Daily log
7.2/10
stable · +0.1 vs previous 14 d
Steps
Wearable
3,582
stable · -28 vs previous 14 d
Adherence
Companion
63.9 %
worsening · -10.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 36 from the failing basin, 52 from restoration.

Good elements to keep
  • Stable without identifiable pulls.
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • FUT2 non-secretor
    hidden · steering -10.6
  • Dietary fat load
    perturbation · steering -9
  • Histamine load
    perturbation · steering -7.8
  • Dietary fat load
    detractor · GI +4.8 next day
  • Histamine load
    detractor · GI +4.6 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +4.8detractor · 95%
  • Histamine load
    +4.6detractor · 95%
  • Simple carbohydrates
    -1.6no signal · 43%
  • Spicy / capsaicin
    -1no signal · 22%
  • Alcohol
    +0.8no signal · 22%
  • Insoluble fibre
    +0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 53
    • WearableHRV 37 ms, trending down
  • Autonomic recovery 65
    • WearableResting HR 79 bpm
    • Wearable3,582 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Daily logGI symptom score 50 and rising
    • WearableSleep 5.3 h, below personal baseline
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 40/100
    • Daily logFibre intake low in recent food logs
  • Drug metabolism and exposure 20
    • BloodToxicity index 58
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 40/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
29 ms
Sleep
5.3 h
Steps
2,924
Resting HR
81 bpm
Daily log: GI score 50, nutritional resilience 46, adherence 64.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0179451%S0954
P-0131050%S0157
P-0179549%S0661
P-0146947%S1958
P-0147047%S1655
P-0162345%S1652
P-0170845%S07CR-01improved59
P-0171545%S0556
P-0176945%S2060
P-0169744%S0955
P-0172544%S18GI-04no change56
P-0145941%S0251